ArticleEuropean heart journal2021

Personalized anti-thrombotic management of patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1 — a statement of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke [corrected].

Patrick Sulzgruber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.